GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WuXi Biologics (Cayman) Inc (HKSE:02269) » Definitions » Inventory Turnover

WuXi Biologics (Cayman) (HKSE:02269) Inventory Turnover : 3.31 (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is WuXi Biologics (Cayman) Inventory Turnover?

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. WuXi Biologics (Cayman)'s Cost of Goods Sold for the six months ended in Dec. 2024 was HK$6,193 Mil. WuXi Biologics (Cayman)'s Average Total Inventories for the quarter that ended in Dec. 2024 was HK$1,869 Mil. WuXi Biologics (Cayman)'s Inventory Turnover for the quarter that ended in Dec. 2024 was 3.31.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. WuXi Biologics (Cayman)'s Days Inventory for the six months ended in Dec. 2024 was 55.07.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. WuXi Biologics (Cayman)'s Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.17.

WuXi Biologics (Cayman) Inventory Turnover Historical Data

The historical data trend for WuXi Biologics (Cayman)'s Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WuXi Biologics (Cayman) Inventory Turnover Chart

WuXi Biologics (Cayman) Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventory Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.22 3.99 4.14 4.99 6.62

WuXi Biologics (Cayman) Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Inventory Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.10 2.30 2.83 2.78 3.31

WuXi Biologics (Cayman) Inventory Turnover Calculation

WuXi Biologics (Cayman)'s Inventory Turnover for the fiscal year that ended in Dec. 2024 is calculated as

Inventory Turnover (A: Dec. 2024 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (A: Dec. 2024 ) / ((Total Inventories (A: Dec. 2023 ) + Total Inventories (A: Dec. 2024 )) / count )
=11770.605 / ((1931.341 + 1624.643) / 2 )
=11770.605 / 1777.992
=6.62

WuXi Biologics (Cayman)'s Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover (Q: Dec. 2024 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (Q: Dec. 2024 ) / ((Total Inventories (Q: Jun. 2024 ) + Total Inventories (Q: Dec. 2024 )) / count )
=6192.805 / ((2112.764 + 1624.643) / 2 )
=6192.805 / 1868.7035
=3.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

WuXi Biologics (Cayman)  (HKSE:02269) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

WuXi Biologics (Cayman)'s Days Inventory for the six months ended in Dec. 2024 is calculated as:

Days Inventory =Average Total Inventories (Q: Dec. 2024 )/Cost of Goods Sold (Q: Dec. 2024 )*Days in Period
=1868.7035/6192.805*365 / 2
=55.07

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

WuXi Biologics (Cayman)'s Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=1868.7035 / 10784.723
=0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

WuXi Biologics (Cayman) Inventory Turnover Related Terms

Thank you for viewing the detailed overview of WuXi Biologics (Cayman)'s Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

WuXi Biologics (Cayman) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WuXi Biologics (Cayman) Inc (HKSE:02269) » Definitions » Inventory Turnover
Comparable Companies
HKSE:01801 HKSE:09926 HKSE:01177 HKSE:06990 HKSE:01877 HKSE:09995 HKSE:01530 HKSE:01548 HKSE:02696 HKSE:09969 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
WXIBF:USA WXXWY:USA 1FW2:Germany
Address
No. 108, Meiliang Road, Mashan Binhu District, Wuxi, CHN, 214092
Website
https://www.wuxibiologics.com
WuXi Biologics is one of the largest global biologic global contract development and manufacturing organizations. WuXi Biologics, incorporated in 2014 following the reorganization of WuXi PharmaTech, later known as WuXi AppTec, now has global revenue of CNY 18.7 billion. North America represented 57.3% of total revenue in 2024. The firm has a "follow and win the molecule" strategy by providing end-to-end services, from drug discovery to commercial manufacturing. It also adopts a global dual sourcing strategy by providing drug products and drug substance manufacturing.
Executives
Li Ge 2201 Interest of corporation controlled by you
Liu Xiaozhong 2401 A concert party to an agreement to buy shares
New Wuxi Life Science Holdings Limited 2201 Interest of corporation controlled by you
New Wuxi Life Science Limited 2201 Interest of corporation controlled by you
Wuxi Biologics Holdings Limited 2101 Beneficial owner
Wuxi Pharmatech (cayman) Inc. 2201 Interest of corporation controlled by you
Zhang Zhaohui 2401 A concert party to an agreement to buy shares
Blackrock, Inc. 2201 Interest of corporation controlled by you
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Citigroup Inc. 2502 Approved lending agent
Brown Brothers Harriman & Co. 2502 Approved lending agent
Zhao Ning 2202 Interest of your spouse
The Capital Group Companies, Inc. 2201 Interest of corporation controlled by you

WuXi Biologics (Cayman) Headlines

No Headlines